BofA upgrades Avnet stock rating on improving cycle indicators By Investing.com

BofA Securities upgraded Avnet to Neutral from Underperform and lifted its price target to $96 from $66, citing backlog strength, book-to-bill ratios above 1, and normalized inventory at 77 days. The firm also raised its calendar 2027 EPS estimate to $9.06 from $8.66 and moved to an 11x multiple from 8x, though it remains cautious on end-demand pull-forward and margin upside. Separately, Avnet beat fiscal Q3 2026 expectations with EPS of $1.48 versus $1.31 and revenue of $7.1B versus $6.4B.

Analysis

The important read-through is not just that AVT is improving, but that the cycle is broadening from inventory digestion to actual order normalization. When backlog extends and book-to-bill clears 1 across geographies, distributors start to regain pricing power before end-demand fully recovers, which can mechanically lift gross margin with a lag of 1-2 quarters. That creates a favorable setup for high-quality distribution names, but also means the market often prices the inflection early and then stalls if the end-market data fail to confirm.

The second-order winner is likely upstream component suppliers with higher operating leverage, since a cleaner channel usually leads to faster replenishment orders than end-market sales growth would imply. The risk is that distributor share gains in the upcycle can mask a demand pull-forward problem: if customers are rebuilding inventories rather than consuming them, margin and revenue momentum can fade by mid-to-late 2026. That is especially relevant because the market is now valuing AVT more like a mid-cycle compounder than a cyclical; any evidence that industrial, communications, or computing demand is merely stabilizing rather than accelerating would compress the multiple.

Consensus appears to be underestimating how much of the earnings revision is already in the stock. After a large six-month rerating, the next leg likely requires either a second derivative in bookings or a visible operating-margin inflection; without that, upside may be capped even if estimates creep higher. Conversely, if Farnell normalizes faster than expected or regional mix improves, AVT can still outperform because the market is underpricing operating leverage in a cleaner inventory environment. The key contrarian view is that this is now a quality-of-cycle story, not a simple cycle-recovery story, so the stock is more fragile to macro disappointment than the current bullish tone suggests.

Key Decisions for Investors

• Stay long AVT only on pullbacks into the low-$80s with a 3-6 month horizon; risk/reward is acceptable if you believe the next two quarters confirm backlog conversion, but upside looks more limited after the rerate unless margins surprise higher.
• Pair trade: long AVT / short a more levered industrial-electronics or components proxy over the next 1-2 quarters; the cleaner balance sheet and visible cycle indicators should outperform if the channel recovery is real, but the short leg protects against a broad multiple reset.
• Use call spreads rather than outright longs in AVT for a 6-9 month trade; the stock has already discounted a decent portion of the upcycle, so defined-risk upside participation is better than paying full delta.
• Watch for confirmation in channel inventory data and book-to-bill over the next earnings cycle; if these roll over, reduce exposure quickly because the market will likely de-rate the multiple before earnings estimates fall.
• If AVT breaks above prior highs on improving gross margin commentary, consider adding to long exposure as that would signal the market is finally assigning value to operating leverage rather than just cyclical normalization.